Investigated event: Influence on cell viability
| Name | Value |
|---|---|
| Compound | Ly5 |
| Investigated event | Influence on cell viability |
| Experiment type | Alamar Blue staining |
| Concentration | N/A nM |
| Cell line | Rh30 |
| Organism | Homo sapiens |
| Animal model | |
| STAT protein | |
| Other |
Reference
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PloS one Peter Y Yu, Heather L Gardner, Ryan Roberts, Hakan Cam, Seethalakshmi Hariharan, Ling Ren, Amy K LeBlanc, Hui Xiao, Jiayuh Lin, Denis C Guttridge, Xiaokui Mo, Chad E Bennett, Christopher C Coss, Yonghua Ling, Mitch A Phelps, Peter Houghton, Cheryl A London, 12, 7, None, 2017-07-27, 10.1371/journal.pone.0181885
DOI: 10.1371/journal.pone.0181885
PUBMED: 28750090
PMCID: PMC5531494